Cornea metaphase preservation liquid and preparation method thereof
A technology of preservation solution and cornea, which is applied in the preservation, application, and animal husbandry of human or animal bodies. It can solve the problems of impossibility of penetrating corneal transplantation and reduction, and maintain the activity and normal shape of corneal endothelial cells, enhance Effects on viability and less cell fusion
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] A medium-term corneal preservation solution, which is a MEM cell culture medium containing chondroitin sulfate, low-molecular dextran, L-glutamine, fetal bovine serum, tobramycin, Hepes and rapamycin, Wherein the concentration of each component is as follows: chondroitin sulfate 25g / L, low molecular weight dextran 10g / L, L-glutamine 0.375mg / L, fetal bovine serum 5%, tobramycin 0.1g / L, Hepes9. 5g / L, rapamycin 1nM / L.
[0028] The preparation method of above-mentioned medium-term preservation solution of cornea comprises:
[0029] 1) According to the instructions of the MEM medium, take 9.4g of MEM medium powder and add 500ml of water for injection, dissolve and then filter and sterilize to prepare the MEM medium;
[0030] 2) Take 25g of chondroitin sulfate and add 200ml of water for injection, dissolve and filter to sterilize to prepare a chondroitin sulfate solution of 125g / L; take 10g of low-molecular dextran (average molecular weight 20000-40000kD) and add 100ml of wa...
Embodiment 2
[0035] In this embodiment, the concentration of each component in the medium-term corneal preservation solution is as follows: 21 g / L of chondroitin sulfate, 9 g / L of low molecular weight dextran, 0.372 mg / L of L-glutamine, and 3% of fetal bovine serum , Tobramycin 0.09g / L, Hepes9.2g / L, rapamycin 0.95nM / L. All the other are with embodiment 1.
Embodiment 3
[0037] In this embodiment, the concentration of each component in the medium-term corneal preservation solution is as follows: chondroitin sulfate 24g / L, low molecular weight dextran 11g / L, L-glutamine 0.378mg / L, fetal bovine serum 4% , Tobramycin 0.11g / L, Hepes9.8g / L, rapamycin 1.05nM / L.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com